| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.097 | 0.005 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.15 | 0.005 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.13 | 0.005 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.006 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.098 | 0.006 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.098 | 0.006 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | 0.2 | 0.007 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.097 | 0.007 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.089 | 0.008 |